Skip to main content

2 Result(s)

within S J Noga Remove this filter Intensive / Critical Care Medicine Remove this filter

and

  1. No Access

    Article

    Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study

    This phase 1 study (Clinicaltrials.gov: NCT00507442) was conducted to determine the maximum tolerated dose (MTD) of cyclophosphamide in combination with bortezomib...

    S K Kumar, I Flinn, S J Noga, P Hari, R Rifkin, N Callander, M Bhandari… in Leukemia (2010)

  2. No Access

    Chapter and Conference Paper

    Cell Manipulation and Engineering — State of the Art and Future Developments

    Within the last 5 years, the new field of somatic cell therapy (SCRx) has gone through exponential growth. This term was coined by the U.S.Food and Drug Administration (FDA) in guidance documents to encompass ...

    S. J. Noga in Cellular Engineering and Cellular Therapies (2003)